Correction: This article has been corrected to relect that this is not a new suit, but rather a lawsuit that is a couple of years old that was transferred from Maryland to Texas. Court documents did not disclose that the suit was transferred, but rather was listed as a new filing.

NEW YORK (GenomeWeb News) – A lawsuit that Invitrogen, a division of Life Technologies, filed against GE Healthcare a couple of years ago alleging infringement of several patents held by Invitrogen has been transferred to a Texas court from Maryland.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.